Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study

NCT: NCT05054699 · ACTIVE_NOT_RECRUITING

NCT IDNCT05054699
StatusACTIVE_NOT_RECRUITING
Start Date2021-05-31
Completion2026-06-30

Brief Summary

This study aims to compare the efficacy and safety profile of Magnetic Seizure Therapy and Electroconvulsive therapy.

Frequently Asked Questions

What is Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study?

Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study is a clinical trial registered under NCT05054699. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05054699?

The current status of NCT05054699 (Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study) is: ACTIVE_NOT_RECRUITING.

When did Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study start?

Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study started on 2021-05-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑